Guangzhou LBP Medicine Science & Technology Co., Ltd. (688393.SS)
CNY 19.28
(0.47%)
CNY 19.28
(0.47%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 497.29 Million | 507.38 Million | 438.98 Million | 375.43 Million | 355.15 Million | 306.29 Million |
| Cost of Revenue | 161.87 Million | 146.75 Million | 96.94 Million | 75.96 Million | 57.94 Million | 52.17 Million |
| Gross Profit | 335.41 Million | 360.63 Million | 342.04 Million | 299.46 Million | 297.21 Million | 254.12 Million |
| Operating Expenses | 319.1 Million | 329.02 Million | 274.99 Million | 203.72 Million | 208.94 Million | 179.43 Million |
| Selling, General and Administrative Expenses | 200.71 Million | 206.42 Million | 198.5 Million | 164.17 Million | 167.03 Million | 146.58 Million |
| Research and Development Expenses | 62.68 Million | 67.39 Million | 45.9 Million | 27.73 Million | 21.85 Million | 15.58 Million |
| Other Expenses | -12.06 Million | 55.2 Million | 30.59 Million | 11.82 Million | 20.04 Million | 110.16 Thousand |
| Cost and Expenses | 475.77 Million | 475.77 Million | 371.94 Million | 279.69 Million | 266.88 Million | 231.6 Million |
| Operating Income | 21.51 Million | 38.85 Million | 88.94 Million | 100.19 Million | 88.79 Million | 74.36 Million |
| Interest Expense | 949.49 Thousand | 1.35 Million | 384.1 Thousand | 73.76 Thousand | 113.43 Thousand | 18 Thousand |
| Income Tax Expense | -4.16 Million | -539.22 Thousand | 13.44 Million | 16.23 Million | 14.44 Million | 12.05 Million |
| Earnings before Tax | 16.84 Million | 28.79 Million | 88.72 Million | 99.85 Million | 87.24 Million | 74.47 Million |
| Net Income | 40.05 Million | 29.33 Million | 79.77 Million | 84.74 Million | 73.98 Million | 61.47 Million |
| Earnings Per Share Basic | 0.43 | 0.31 | 0.85 | 0.91 | 0.79 | 0.88 |
| Earnings Per Share Diluted | 0.42 | 0.31 | 0.85 | 0.91 | 0.79 | 0.88 |
| Weighted Average Shares Outstanding | 93.15 Million | 93.34 Million | 93.34 Million | 93.34 Million | 93.34 Million | 69.85 Million |
| Weighted Average Shares Outstanding (Diluted) | 95.37 Million | 94.87 Million | 93.34 Million | 93.34 Million | 93.34 Million | 69.85 Million |
| Gross Margin | 0.67 | 0.71 | 0.78 | 0.80 | 0.84 | 0.83 |
| EBIT Margin | 0.13 | 0.15 | 0.24 | 0.30 | 0.29 | 0.30 |
| Profit Margin | 0.08 | 0.06 | 0.18 | 0.23 | 0.21 | 0.20 |
| EBITDA | 66.48 Million | 71.38 Million | 111.25 Million | 111.56 Million | 99.6 Million | 87.74 Million |
| Earnings Before Tax Margin | 0.04 | 0.08 | 0.20 | 0.27 | 0.25 | 0.24 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 124.61 Million | 125.44 Million | 101.46 Million | 497.29 Million | 142.78 Million | 143.55 Million |
| Cost of Revenue | 44.21 Million | 46.82 Million | 28.28 Million | 23.36 Million | 47.66 Million | 49.47 Million |
| Gross Profit | 80.39 Million | 78.61 Million | 73.18 Million | 473.93 Million | 95.12 Million | 94.07 Million |
| Operating Expenses | 68.67 Million | 81.07 Million | 70.74 Million | 320.44 Million | 93.59 Million | 77.17 Million |
| Selling, General and Administrative Expenses | 133.05 Million | 68.56 Million | 64.88 Million | - | 16.3 Million | 87.83 Million |
| Research and Development Expenses | 7.56 Million | 12.48 Million | 8.74 Million | - | 18.08 Million | 16.66 Million |
| Other Expenses | -71.93 Million | -22.24 Thousand | -275.85 Thousand | -4.66 Million | -709.66 Thousand | -2.45 Million |
| Cost and Expenses | 112.89 Million | 127.9 Million | 99.03 Million | 23.36 Million | 141.25 Million | 126.65 Million |
| Operating Income | 13.2 Million | -2.46 Million | 3.92 Million | 473.93 Million | -2.88 Million | 17.24 Million |
| Interest Expense | 123.37 Thousand | 263.03 Thousand | 11.77 Thousand | 808.03 Thousand | 190.66 Thousand | 258.39 Thousand |
| Income Tax Expense | 1.09 Million | -4.23 Million | -137.28 Thousand | -4.16 Million | -5.77 Million | 407.52 Thousand |
| Earnings before Tax | 11.98 Million | 4.42 Million | 3.64 Million | 18.69 Million | -3.58 Million | 14.79 Million |
| Net Income | 13.26 Million | 8.37 Million | 7.98 Million | 40.05 Million | 2.46 Million | 19.48 Million |
| Earnings Per Share Basic | 0.14 | 0.09 | 0.09 | - | 0.03 | 0.21 |
| Earnings Per Share Diluted | 0.14 | 0.09 | 0.08 | - | 0.03 | 0.20 |
| Weighted Average Shares Outstanding | 93.56 Million | 93.56 Million | 88.77 Million | 93.72 Million | 92.93 Million | 93.56 Million |
| Weighted Average Shares Outstanding (Diluted) | 93.56 Million | 93.56 Million | 99.86 Million | 93.72 Million | 92.93 Million | 97.44 Million |
| Gross Margin | 0.65 | 0.63 | 0.72 | 0.95 | 0.67 | 0.66 |
| EBIT Margin | 0.10 | 0.08 | 0.05 | - | 0.01 | 0.12 |
| Profit Margin | 0.11 | 0.07 | 0.08 | 0.08 | 0.02 | 0.14 |
| EBITDA | 12.11 Million | 9.88 Million | 4.64 Million | - | 1.56 Million | 17.2 Million |
| Earnings Before Tax Margin | 0.11 | -0.02 | 0.04 | 0.95 | -0.02 | 0.12 |
YARIY
600223
688018
GEMD
605081
0R33